Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd-R Burmester

Showing results (1-10 of 293) with videos related to

Pageof 30
Sort By:
Nature Reviews. Rheumatology|January 11, 2012
RA in 2011: Advances in diagnosis, treatment and definition of remissionGerd R Burmester
Autoimmunity Reviews|November 18, 2004
Strategies using functional genomics in rheumatic diseasesGerd R Burmester, Thomas Häupl
Current Opinion in Rheumatology|April 23, 2003
The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targetsThomas Dörner, Gerd R Burmester
Nature Clinical Practice. Rheumatology|March 3, 2009
Is tocilizumab in combination with traditional DMARDs safe and effective for patients with active RA?Eugen Feist, Gerd-R Burmester
Expert Opinion on Biological Therapy|October 20, 2010
Canakinumab for treatment of cryopyrin-associated periodic syndromeEugen Feist, Gerd R Burmester
Current Opinion in Rheumatology|April 5, 2008
New approaches of B-cell-directed therapy: beyond rituximabThomas Dörner, Gerd R Burmester
Rheumatology (Oxford, England)|February 5, 2013
Small molecules targeting JAKs--a new approach in the treatment of rheumatoid arthritisEugen Feist, Gerd R Burmester
European Journal of Immunology|August 13, 2009
A clinical perspective of rheumatoid arthritisHans Ulrich Scherer, Gerd R Burmester
Lancet (London, England)|June 15, 2017
Novel treatment strategies in rheumatoid arthritisGerd R Burmester, Janet E Pope
Nature Reviews. Rheumatology|November 13, 2013
Emerging cell and cytokine targets in rheumatoid arthritisGerd R Burmester, Eugen Feist, Thomas Dörner
Pageof 30

Showing results (1-10 of 293) with videos related to

Sort By:
Pageof 30
Nature Reviews. Rheumatology|January 11, 2012
RA in 2011: Advances in diagnosis, treatment and definition of remissionGerd R Burmester
Autoimmunity Reviews|November 18, 2004
Strategies using functional genomics in rheumatic diseasesGerd R Burmester, Thomas Häupl
Current Opinion in Rheumatology|April 23, 2003
The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targetsThomas Dörner, Gerd R Burmester
Nature Clinical Practice. Rheumatology|March 3, 2009
Is tocilizumab in combination with traditional DMARDs safe and effective for patients with active RA?Eugen Feist, Gerd-R Burmester
Expert Opinion on Biological Therapy|October 20, 2010
Canakinumab for treatment of cryopyrin-associated periodic syndromeEugen Feist, Gerd R Burmester
Current Opinion in Rheumatology|April 5, 2008
New approaches of B-cell-directed therapy: beyond rituximabThomas Dörner, Gerd R Burmester
Rheumatology (Oxford, England)|February 5, 2013
Small molecules targeting JAKs--a new approach in the treatment of rheumatoid arthritisEugen Feist, Gerd R Burmester
European Journal of Immunology|August 13, 2009
A clinical perspective of rheumatoid arthritisHans Ulrich Scherer, Gerd R Burmester
Lancet (London, England)|June 15, 2017
Novel treatment strategies in rheumatoid arthritisGerd R Burmester, Janet E Pope
Nature Reviews. Rheumatology|November 13, 2013
Emerging cell and cytokine targets in rheumatoid arthritisGerd R Burmester, Eugen Feist, Thomas Dörner
Pageof 30